Fairvalue-Calculator Fairvalue-Calculator
EN DE

CIRSA (CIRSA) Fair Value & Analysis

Consumer Cyclical · Market cap €2.1B

C CIRSA CIRSA · MC
Price€12.40
Fair Value€8.69
Upside-29.9%
Quality91/100
Evidence: High Range €6.52 – €10.86

Fair value as of: Jul 1, 2026

From 26 valuation models · updated today

Share price −2.1% over the past month.

Price vs Fair Value (12 months)

€16.23 €12.22 Fair Value €8.69 Jul 2025 Jun 2026

12‑month range €12.22 – €16.23 · fair‑value band €6.52 – €10.86 · the €12.40 price screens above the €8.69 fair value. As of Jul 1, 2026.

✦ Find undervalued quality stocks — 35,000+ analysed Find stocks →

Analysis

CIRSA (CIRSA) currently trades at €12.40, while our model-based Fair Value estimate is €8.69 — implying the stock looks roughly 29.9% overvalued today. We read business quality at 91/100 (high quality), in the Consumer Cyclical sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

Net debt stands at €1.9B. The stock trades on a trailing P/E of 23.4. Fundamentals as of Jul 1, 2026

Key figures & financial health

Revenue (TTM) €2.4B
Revenue growth (YoY) +8.0%
Net margin 3.7%
Return on equity 25.2%
Free cash flow €436M FY2025
P/E ratio 23.4
More key figures
Operating margin 15.5%
EPS (TTM) €0.5300
Dividend yield 3.6%
EPS growth (YoY) -22.1%
Net debt €1.9B FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 1, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

CIRSA reported revenue of €1.7B in FY2025 versus €798M in FY2021, a compound +19.9%/yr. Reported net income was €72.9M in FY2025.

Revenue +19.9%/yr
FY21 €798M
FY22 €1.7B
FY23 €2.0B
FY24 €2.2B
FY25 €1.7B
Net income
FY21 −€151M
FY22 €56.6M
FY23 €80.0M
FY24 €12.6M
FY25 €72.9M

Open the full interactive analysis →

Similar stocks

6 more Resorts & Casinos stocks, each showing price versus our Fair Value estimate (as of Jul 1, 2026).

Stock Price Fair Value vs Fair Value
Las Vegas Sands Corp LVS $50.25 $40.05 -20%
Galaxy Entertainment Group GXYEF $3.78 $6.82 +81%
Sands China Ltd SCHYF $1.80 $2.18 +21%
MGM Resorts International, through its subsidiaries, MGM $46.91 $20.81 -56%
Wynn Resorts, Limited WYNN $105.26 $28.17 -73%
MGM China Holdings MCHVF $1.50 $2.74 +83%

Explore undervalued stocks

More undervalued Consumer Cyclical stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is CIRSA (CIRSA) undervalued?
As of Jul 1, 2026, our model estimates a fair value of €8.69 versus a price of €12.40 — about −30% (overvalued). Model-based estimate, not financial advice.
What is the fair value of CIRSA?
Our 21-model fair value for CIRSA is €8.69 (as of Jul 1, 2026), built from audited fundamentals. The current price is €12.40.
What is the quality score of CIRSA?
CIRSA has a Quality Score of 91/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the net profit margin of CIRSA?
The net profit margin of CIRSA is about 0.0%, meaning it keeps roughly 0.0% of revenue as net income. Based on the latest reported figures.
Does CIRSA pay a dividend?
CIRSA currently shows a dividend yield of about 3.60% relative to its recent price (as of Jul 1, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.